Roche Pharma India and SKCC, USA launch ACMO in India for oncologists/pathologists
One-of-its-kind programme to train more than 100 cancer specialists, pathologists in personalised medicine
Roche Pharma India, in partnership with Sidney Kimmel Cancer Center (SKCC) – Jefferson Health, Pennsylvania, USA and BioQuest Solutions, has launched a one-of-its-kind Advanced Certification Programme in Molecular Oncology (ACMO) to equip oncologists and pathologists in the country with methods of genomic/personalised medicine, a statement from Roche Pharma India informed.
Around 100 healthcare professionals, including 70 oncologists and 30 pathologists from across the country will be trained under this programme. Comprising 14 online modules, the programme spreads over eight months and aims to provide comprehensive, evidence-based updates on personalised medicine, said the statement.
The programme faculty will include professors from various departments affiliated to the Thomas Jefferson University, including oncology, urology, computational medicine, biochemistry and molecular biology. Interspersed with live virtual sessions, the online programme is a case-based and self-learning, interactive certification course, the statement concluded.
- Advertisement -
I love your great blog, thanks a lot and keep up the good work.